Pharmafile Logo

Kathryn Gallant leaves Hall & Partners to join Insight Health US

Appointed joint CEO alongside Jessica Cunningham

Kathryn Gallan, Insight Health USConsultancy firm Insight Health US has appointed former managing partner at Hall & Partners Kathryn Gallant as joint CEO.

Gallant joins fellow CEO Jessica Cunningham at the New York-based firm, where she replaces Avanti Ananthram who is due to move to the UK to become head of international development at parent company Insight Research Group.

Gallant’s duties will include driving the growth of Insight Health US.

In total, Gallant has 14 years’ experience in market research spanning both global and US domestic healthcare research, eight of which have been at Hall & Partners.

Prior to this, she was a director at Strategic Marketing Corporation.

Jane Shirley, CEO of Insight Research Group, said: “We are delighted that Kathryn will be joining us to help drive the next stage of Insight’s growth in the US. Kathryn has a great reputation within the industry that fits perfectly with Insight’s focus on delivering top quality, truly insightful research.”

Article by Dominic Tyer
15th January 2013
From: Sales
Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links